ClinicalTrials.Veeva

Menu

Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-Thoracotomy (STEMDILCARD)

I

Instituto de Cardiologia do Rio Grande do Sul

Status and phase

Completed
Phase 2
Phase 1

Conditions

Dilated Cardiomyopathy

Treatments

Procedure: intramyocardial bone marrow stem cells implantation

Study type

Interventional

Funder types

Other

Identifiers

NCT00615394
UP3549/04

Details and patient eligibility

About

Bone marrow mononuclear cells (BMMC) transplantation is a promising therapy for treating ischemic disease, however the effect in non-ischemic dilated cardiomyopathy is unknown.This study describes a technique of BMMC transplantation utilizing mini-thoracotomy and results up to one year after the procedure.

Enrollment

6 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis made at more than two years and symptomatic at functional class III-IV by the New York Heart Association classification (NYHA) despite optimal pharmacologic therapy
  • left ventricular ejection fraction (LVEF) less than 35%, by echocardiogram
  • age below 60 years
  • absence of neoplasm
  • absence of hematologic disease or systemic disease
  • no previous cardiac intervention

Exclusion criteria

  • episodes of tachycardia or ventricular fibrillation
  • severe or moderated mitral insufficiency
  • any other valvulopathies

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems